Advertisement
Screener

TELADOC HEALTH, INC. (TDOC) Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

2.6 / 5 stars · 50/95 Roast Me

TELADOC HEALTH, INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price

TELADOC HEALTH, INC. (TDOC) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-26

  • TELADOC HEALTH, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $20.66, a 12.64% decline year-over-year.
  • TELADOC HEALTH, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $23.65.
  • TELADOC HEALTH, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
  • TELADOC HEALTH, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $20.66, a 1.03% increase from fiscal 2023.
  • TELADOC HEALTH, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $20.45.
  • TELADOC HEALTH, INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2016 was $14.58.
Period endShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 monthShare-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month
2025-12-31$0.00
10-K · filed 2026-02-26
2024-12-31$20.66
10-K · filed 2025-02-27
2024-09-30$20.66
10-Q · filed 2024-10-31
2024-06-30$20.66
10-Q · filed 2024-08-01
2024-03-31$20.66
10-Q · filed 2024-04-26
2023-12-31$20.45
10-K · filed 2024-02-23
2023-09-30$24.27
10-Q · filed 2023-10-27
2023-06-30$24.37
10-Q · filed 2023-07-28
2023-03-31$23.65
10-Q · filed 2023-05-02
2022-09-30$34.33
10-Q · filed 2022-11-02
2022-06-30$34.36
10-Q · filed 2022-08-03
2016-12-31$14.58
10-K · filed 2017-03-01
2014-12-31$5.53
10-K · filed 2017-03-01
2013-12-31$1.07
10-K · filed 2016-03-03

Similar stocks

Stock NameCountryMarket CapPE Ratio
SBC Medical Group Holdings Inc (SBC)United States$0.487B
Airsculpt Technologies, Inc. (AIRS)United States$0.146B-27.36
LifeMD, Inc. (LFMD)United States$0.141B982.53